British surgeon Ara Darzi told WIRED Health that artificial intelligence has significant potential to improve diagnosis and treatment of antibiotic-resistant infections. However, weak market incentives threaten to delay these innovations from reaching patients.
Antibiotic resistance kills an estimated 1.27 million people globally each year and is projected to become a leading cause of death by 2050. AI offers a pathway to address this crisis by accelerating drug discovery, identifying resistant pathogens faster, and personalizing treatment plans.
Darzi, a prominent figure in healthcare innovation, emphasized AI's transformative capacity at the health conference. The technology can analyze vast datasets to predict resistance patterns and recommend targeted interventions more effectively than traditional methods.
The barrier to implementation is economic. Pharmaceutical companies have limited financial incentive to develop treatments for drug-resistant infections due to smaller patient populations and lower profit margins compared to blockbuster drugs. Without stronger market rewards or regulatory support, promising AI-driven solutions risk remaining in laboratories rather than hospitals.
Experts argue that addressing this gap requires policy changes, including improved reimbursement models and incentive structures that encourage companies to invest in resistance-fighting innovations.
Israel-based Hemispheric secured $52 million in funding for its AI model that analyzes non-invasive brain activity measurements and converts them into quantitative diagnostic metrics.
Anthropic and Blackstone are backing Ode, a new venture that embeds AI engineers directly inside enterprises. The bet signals a shift in where the next trillion dollars in AI value may be created: not in building models, but in implementing them.
Spectro Cloud, an AI infrastructure company focused on managing token costs, secured $100 million in Series D funding at a valuation exceeding $1 billion. The raise marks significant growth from the company's $750 million valuation in 2024.
Startups like Altur are deploying AI chatbots to handle debt collection calls, automating a process traditionally done by humans. Y Combinator has backed six debt collection and settlement startups over the past six years.